STERIS plc (NYSE:STE) Shares Purchased by Running Oak Capital LLC

Running Oak Capital LLC grew its position in shares of STERIS plc (NYSE:STE) by 18.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 40,738 shares of the medical equipment provider’s stock after purchasing an additional 6,260 shares during the quarter. Running Oak Capital LLC’s holdings in STERIS were worth $8,956,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of STE. SRS Capital Advisors Inc. boosted its position in shares of STERIS by 74.0% in the fourth quarter. SRS Capital Advisors Inc. now owns 764 shares of the medical equipment provider’s stock worth $168,000 after buying an additional 325 shares during the period. First Horizon Advisors Inc. grew its position in shares of STERIS by 9.3% in the fourth quarter. First Horizon Advisors Inc. now owns 1,011 shares of the medical equipment provider’s stock valued at $222,000 after purchasing an additional 86 shares during the last quarter. New York Life Investment Management LLC grew its holdings in STERIS by 9.4% in the 4th quarter. New York Life Investment Management LLC now owns 15,450 shares of the medical equipment provider’s stock valued at $3,397,000 after buying an additional 1,333 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in STERIS by 16.3% in the 4th quarter. Victory Capital Management Inc. now owns 68,274 shares of the medical equipment provider’s stock valued at $15,010,000 after purchasing an additional 9,555 shares during the period. Finally, Berry Wealth Group LP acquired a new stake in STERIS during the fourth quarter worth about $326,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. TheStreet raised STERIS from a “c+” rating to a “b” rating in a report on Wednesday, February 7th. Stephens reiterated an “overweight” rating and issued a $250.00 price objective on shares of STERIS in a research report on Friday, February 9th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research note on Friday, April 12th. KeyCorp began coverage on STERIS in a research note on Tuesday, February 6th. They set an “overweight” rating and a $253.00 price objective on the stock. Finally, JMP Securities reissued a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, February 8th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $239.60.

STERIS Trading Up 0.6 %

STE traded up $1.20 during trading on Thursday, reaching $206.24. 384,284 shares of the stock traded hands, compared to its average volume of 458,173. The company has a quick ratio of 1.49, a current ratio of 2.43 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $20.38 billion, a PE ratio of 35.91 and a beta of 0.81. The stock’s 50-day moving average is $219.61 and its 200 day moving average is $216.36. STERIS plc has a 12 month low of $185.22 and a 12 month high of $254.00.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.17 by $0.05. The company had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.35 billion. STERIS had a net margin of 10.48% and a return on equity of 13.67%. The firm’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.02 EPS. Equities analysts anticipate that STERIS plc will post 8.67 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Wednesday, June 12th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 1.01%. The ex-dividend date is Wednesday, June 12th. STERIS’s dividend payout ratio (DPR) is presently 36.43%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.